Bulis Veronica Sanchez
SEC insider (Form 3/4/5 filer). CIK 0002095702. VP, Corporate Controller at Lyell Immunopharma, Inc. (LYEL). 7 reported Form 4/5 transactions since Sep 2024; latest on Aug 10, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies Bulis Veronica Sanchez has filed insider reports for
- Lyell Immunopharma, Inc. (LYEL): Officer, VP, Corporate Controller
Bulis Veronica Sanchez
CIK: 0002095702
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Lyell Immunopharma, Inc.
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Aug 10, 2026LYEL
Lyell Immunopharma, Inc.
SaleDirect621 shares at avg. $14.34$9K - May 11, 2026LYEL
Lyell Immunopharma, Inc.
SaleDirect217 shares at avg. $18.91$4K - Feb 10, 2026LYEL
Lyell Immunopharma, Inc.
AwardDirect8.8K shares- - Feb 10, 2026LYEL
Lyell Immunopharma, Inc.
SaleDirect254 shares at avg. $23.12$6K - Dec 30, 2025LYEL
Lyell Immunopharma, Inc.
SaleDirect936 shares at avg. $32.32$30K - Dec 24, 2025LYEL
Lyell Immunopharma, Inc.
SaleDirect1.1K shares at avg. $38.67$44K - Nov 10, 2025LYEL
Lyell Immunopharma, Inc.
SaleDirect239 shares at avg. $16.10$4K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 10, 2026 | LYEL Lyell Immunopharma, Inc. | Sale | 621 | $14.34 | $8,905 | Direct |
| May 11, 2026 | LYEL Lyell Immunopharma, Inc. | Sale | 217 | $18.91 | $4,103 | Direct |
| Feb 10, 2026 | LYEL Lyell Immunopharma, Inc. | Award | 8,750 | - | $0 | Direct |
| Feb 10, 2026 | LYEL Lyell Immunopharma, Inc. | Sale | 254 | $23.12 | $5,872 | Direct |
| Dec 30, 2025 | LYEL Lyell Immunopharma, Inc. | Sale | 936 | $32.32 | $30,252 | Direct |
| Dec 24, 2025 | LYEL Lyell Immunopharma, Inc. | Sale | 1,136 | $38.67 | $43,929 | Direct |
| Nov 10, 2025 | LYEL Lyell Immunopharma, Inc. | Sale | 239 | $16.10 | $3,848 | Direct |
1-7 of 7 transactions